{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T16:25:46Z","timestamp":1742401546434,"version":"3.28.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,5]]},"DOI":"10.7759\/cureus.73040","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:47:44Z","timestamp":1730807264000},"source":"Crossref","is-referenced-by-count":1,"title":["Gold-Induced Cytokine (GOLDIC) for the Management of Knee Osteoarthritis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Adarsh","family":"Aratikatla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhu Krishnan","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Ghandour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashim","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45435","article-title":"GOLD-Induced Cytokine (GOLDIC): a game-changer orthobiologic in regenerative medicine","volume":"15","author":"Jeyaraman M","year":"2023","unstructured":"Jeyaraman M, Jeyaraman N, Ram PR, Venkatasalam R, Yadav S. GOLD-Induced Cytokine (GOLDIC): a game-changer orthobiologic in regenerative medicine. Cureus. 2023, 15:e45435. 10.7759\/cureus.45435","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5005\/jpmer-52-2-iii-v","article-title":"Biologics and regenerative medicine- what's new, what\u2019s next","volume":"52","author":"Jackson P","year":"2018","unstructured":"Jackson P, Murrell WD. Biologics and regenerative medicine- what's new, what\u2019s next. J Postgrad Med Educ Res. 2018, 52:10.5005\/jpmer-52-2-iii-v","journal-title":"J Postgrad Med Educ Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2217\/rme-2022-0047","article-title":"GOLDIC therapy in degenerative lumbar spinal stenosis: randomized, controlled trial","volume":"17","author":"Godek P","year":"2022","unstructured":"Godek P, Szczepanowska-Wolowiec B, Golicki D. GOLDIC therapy in degenerative lumbar spinal stenosis: randomized, controlled trial. Regen Med. 2022, 17:709-18. 10.2217\/rme-2022-0047","journal-title":"Regen Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7013.1000151","article-title":"First results on the outcome of gold-induced, autologous-conditioned serum (GOLDIC) in the treatment of different lameness-associated equine diseases","volume":"5","author":"Schneider U","year":"2014","unstructured":"Schneider U, Veith G. First results on the outcome of gold-induced, autologous-conditioned serum (GOLDIC) in the treatment of different lameness-associated equine diseases. J Cell Sci Ther. 2014, 5:10.4172\/2157-7013.1000151","journal-title":"J Cell Sci Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000520","article-title":"Injectable gold for rheumatoid arthritis","volume":"1997","author":"Clark P","year":"2000","unstructured":"Clark P, Tugwell P, Bennet K, Bombardier C, Shea B, Wells G, Suarez-Almazor ME. Injectable gold for rheumatoid arthritis. Cochrane Database Syst Rev. 2000, 1997:CD000520. 10.1002\/14651858.CD000520","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-54184-5_39","article-title":"Gold-induced autologous cytokine treatment in Achilles tendinopathy","author":"Schneider U","year":"2017","unstructured":"Schneider U, Wallich R, Felmet G, Murrell WD. Gold-induced autologous cytokine treatment in Achilles tendinopathy. Muscle and Tendon Injuries. Canata GL, d\u2019Hooghe P, Hunt KJ (ed): Springer, Berlin, Heidelberg; 2017. 10:411-9. 10.1007\/978-3-662-54184-5_39"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46231","article-title":"Gold-Induced Cytokine (GOLDIC\u00ae) therapy in the management of knee osteoarthritis: an observational study","volume":"15","author":"Tulpule S","year":"2023","unstructured":"Tulpule S, Jeyaraman M, Jayakumar T, Jeyaraman N, Bapat A, Yadav S. Gold-Induced Cytokine (GOLDIC\u00ae) therapy in the management of knee osteoarthritis: an observational study. Cureus. 2023, 15:e46231. 10.7759\/cureus.46231","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-020-04870-w","article-title":"Intra-articular gold induced cytokine (GOLDIC\u00ae) injection therapy in patients with osteoarthritis of knee joint: a clinical study","volume":"45","author":"Schneider U","year":"2021","unstructured":"Schneider U, Kumar A, Murrell W, Ezekwesili A, Yurdi NA, Maffulli N. Intra-articular gold induced cytokine (GOLDIC\u00ae) injection therapy in patients with osteoarthritis of knee joint: a clinical study. Int Orthop. 2021, 45:497-507. 10.1007\/s00264-020-04870-w","journal-title":"Int Orthop"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07187-3","article-title":"Anti-inflammatory effects of an autologous gold-based serum therapy in osteoarthritis patients","volume":"12","author":"Feldt J","year":"2022","unstructured":"Feldt J, Donaubauer AJ, Welss J, Schneider U, Gaipl US, Paulsen F. Anti-inflammatory effects of an autologous gold-based serum therapy in osteoarthritis patients. Sci Rep. 2022, 12:3560. 10.1038\/s41598-022-07187-3","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s13770-019-00196-w","article-title":"Current progress in tendon and ligament tissue engineering","volume":"16","author":"Lim WL","year":"2019","unstructured":"Lim WL, Liau LL, Ng MH, Chowdhury SR, Law JX. Current progress in tendon and ligament tissue engineering. Tissue Eng Regen Med. 2019, 16:549-71. 10.1007\/s13770-019-00196-w","journal-title":"Tissue Eng Regen Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/03009740510026797","article-title":"Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage","volume":"34","author":"Vuolteenaho K","year":"2005","unstructured":"Vuolteenaho K, Kujala P, Moilanen T, Moilanen E. Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage. Scand J Rheumatol. 2005, 34:475-9. 10.1080\/03009740510026797","journal-title":"Scand J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-004-4225-6","article-title":"Gelsolin superfamily proteins: key regulators of cellular functions","volume":"61","author":"Silacci P","year":"2004","unstructured":"Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci. 2004, 61:2614-23. 10.1007\/s00018-004-4225-6","journal-title":"Cell Mol Life Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199704000-00007","article-title":"Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis","volume":"25","author":"Suhler E","year":"1997","unstructured":"Suhler E, Lin W, Yin HL, Lee WM. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med. 1997, 25:594-8. 10.1097\/00003246-199704000-00007","journal-title":"Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-020-01919-9","article-title":"Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis","volume":"15","author":"Tang JZ","year":"2020","unstructured":"Tang JZ, Nie MJ, Zhao JZ, Zhang GC, Zhang Q, Wang B. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis. J Orthop Surg Res. 2020, 15:403. 10.1186\/s13018-020-01919-9","journal-title":"J Orthop Surg Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.31579\/2690-4861\/318","article-title":"Gold-Induced Cytokine (Goldic\u00ae) - a promising treatment in patients with Grade 4 knee osteoarthritis: a case study","author":"Pithadia P","year":"2023","unstructured":"Pithadia P, Tulpule S, Patel CR. Gold-Induced Cytokine (Goldic\u00ae) - a promising treatment in patients with Grade 4 knee osteoarthritis: a case study. Int J Clin Case Rep Rev. 2023, 10.31579\/2690-4861\/318","journal-title":"Int J Clin Case Rep Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/art.21562","article-title":"Projections of US prevalence of arthritis and associated activity limitations","volume":"54","author":"Hootman JM","year":"2006","unstructured":"Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006, 54:226-9. 10.1002\/art.21562","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-012-2489-y","article-title":"Complications of total knee arthroplasty: standardized list and definitions of the Knee Society","volume":"471","author":"Healy WL","year":"2013","unstructured":"Healy WL, Della Valle CJ, Iorio R, Berend KR, Cushner FD, Dalury DF, Lonner JH. Complications of total knee arthroplasty: standardized list and definitions of the Knee Society. Clin Orthop Relat Res. 2013, 471:215-20. 10.1007\/s11999-012-2489-y","journal-title":"Clin Orthop Relat Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren JH","year":"1957","unstructured":"Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957, 16:494-502. 10.1136\/ard.16.4.494","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381104","article-title":"Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology","volume":"38","author":"Hochberg MC","year":"1995","unstructured":"Hochberg MC, Altman RD, Brandt KD, et al.. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 1995, 38:1541-6. 10.1002\/art.1780381104","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.152017","article-title":"A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project","volume":"70","author":"Navarro-Sarabia F","year":"2011","unstructured":"Navarro-Sarabia F, Coronel P, Collantes E, et al.. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011, 70:1957-62. 10.1136\/ard.2011.152017","journal-title":"Ann Rheum Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.11.634","article-title":"Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?","volume":"56","author":"Creamer P","year":"1997","unstructured":"Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?. Ann Rheum Dis. 1997, 56:634-6. 10.1136\/ard.56.11.634","journal-title":"Ann Rheum Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.06.029","article-title":"Growth factor combination for chondrogenic induction from human mesenchymal stem cell","volume":"320","author":"Indrawattana N","year":"2004","unstructured":"Indrawattana N, Chen G, Tadokoro M, et al.. Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun. 2004, 320:914-9. 10.1016\/j.bbrc.2004.06.029","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jor.20853","article-title":"Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression","volume":"27","author":"McCarrel T","year":"2009","unstructured":"McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009, 27:1033-42. 10.1002\/jor.20853","journal-title":"J Orthop Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v15.i5.400","article-title":"Autologous peripheral blood-derived orthobiologics: different types and their effectiveness in managing knee osteoarthritis","volume":"15","author":"Gupta A","year":"2024","unstructured":"Gupta A, Jain VK. Autologous peripheral blood-derived orthobiologics: different types and their effectiveness in managing knee osteoarthritis. World J Orthop. 2024, 15:400-3. 10.5312\/wjo.v15.i5.400","journal-title":"World J Orthop"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52693","article-title":"Autologous conditioned plasma (ACP) and osteoarthritis of the knee: a review of current clinical evidence","volume":"16","author":"Gupta A","year":"2024","unstructured":"Gupta A, Jain V. Autologous conditioned plasma (ACP) and osteoarthritis of the knee: a review of current clinical evidence. Cureus. 2024, 16:e52693. 10.7759\/cureus.52693","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53118","article-title":"Hyperacute serum and knee osteoarthritis","volume":"16","author":"Gupta A","year":"2024","unstructured":"Gupta A, Aratikatla A. Hyperacute serum and knee osteoarthritis. Cureus. 2024, 16:e53118. 10.7759\/cureus.53118","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53579","article-title":"Autologous protein solution (APS) and osteoarthritis of the knee: a scoping review of current clinical evidence","volume":"16","author":"Gupta A","year":"2024","unstructured":"Gupta A. Autologous protein solution (APS) and osteoarthritis of the knee: a scoping review of current clinical evidence. Cureus. 2024, 16:e53579. 10.7759\/cureus.53579","journal-title":"Cureus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s43465-024-01172-w","article-title":"Growth factor concentrate (GFC) for the management of osteoarthritis of the knee: a systematic review","volume":"58","author":"Gupta A","year":"2024","unstructured":"Gupta A, Maffulli N. Growth factor concentrate (GFC) for the management of osteoarthritis of the knee: a systematic review. Indian J Orthop. 2024, 58:829-34. 10.1007\/s43465-024-01172-w","journal-title":"Indian J Orthop"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00661-y","article-title":"Platelet lysate and osteoarthritis of the knee: a review of current clinical evidence","author":"Gupta A","year":"2024","unstructured":"Gupta A, Maffulli N. Platelet lysate and osteoarthritis of the knee: a review of current clinical evidence. Pain Ther. 2024, 10.1007\/s40122-024-00661-y","journal-title":"Pain Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70985","article-title":"Autologous peripheral blood-derived orthobiologics for the management of hip osteoarthritis: a systematic review of current clinical evidence","volume":"16","author":"Gupta A","year":"2024","unstructured":"Gupta A, Potty AG, Gupta A, Potty A. Autologous peripheral blood-derived orthobiologics for the management of hip osteoarthritis: a systematic review of current clinical evidence. Cureus. 2024, 16:e70985. 10.7759\/cureus.70985","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68963","article-title":"Autologous conditioned serum in knee osteoarthritis: a systematic review of current clinical evidence","volume":"16","author":"Jeyaraman N","year":"2024","unstructured":"Jeyaraman N, Jeyaraman M, Ramasubramanian S, Yadav S, Balaji S, Patro BP, Gupta A. Autologous conditioned serum in knee osteoarthritis: a systematic review of current clinical evidence. Cureus. 2024, 16:e68963. 10.7759\/cureus.68963","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.57539","article-title":"Exosomes for the management of low back pain: a review of current clinical evidence","volume":"16","author":"Gupta A","year":"2024","unstructured":"Gupta A. Exosomes for the management of low back pain: a review of current clinical evidence. Cureus. 2024, 16:e57539. 10.7759\/cureus.57539","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.02.035","article-title":"Cortistatin binds to TNF-\u03b1 receptors and protects against osteoarthritis","volume":"41","author":"Zhao Y","year":"2019","unstructured":"Zhao Y, Li Y, Qu R, et al.. Cortistatin binds to TNF-\u03b1 receptors and protects against osteoarthritis. EBioMedicine. 2019, 41:556-70. 10.1016\/j.ebiom.2019.02.035","journal-title":"EBioMedicine"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12567","article-title":"Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis","volume":"43","author":"Qi C","year":"2016","unstructured":"Qi C, Shan Y, Wang J, Ding F, Zhao D, Yang T, Jiang Y. Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis. Clin Exp Pharmacol Physiol. 2016, 43:528-34. 10.1111\/1440-1681.12567","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/med.20231","article-title":"Multifunctional roles of gelsolin in health and diseases","volume":"32","author":"Li GH","year":"2012","unstructured":"Li GH, Arora PD, Chen Y, McCulloch CA, Liu P. Multifunctional roles of gelsolin in health and diseases. Med Res Rev. 2012, 32:999-1025. 10.1002\/med.20231","journal-title":"Med Res Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092516","article-title":"Plasma gelsolin: indicator of inflammation and its potential as a diagnostic tool and therapeutic target","volume":"19","author":"Piktel E","year":"2018","unstructured":"Piktel E, Levental I, Durna\u015b B, Janmey PA, Bucki R. Plasma gelsolin: indicator of inflammation and its potential as a diagnostic tool and therapeutic target. Int J Mol Sci. 2018, 19:2516. 10.3390\/ijms19092516","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/1947603514520628","article-title":"Systemic administration of granulocyte colony-stimulating factor for osteochondral defect repair in a rat experimental model","volume":"5","author":"Okano T","year":"2014","unstructured":"Okano T, Mera H, Itokazu M, Okabe T, Koike T, Nakamura H, Wakitani S. Systemic administration of granulocyte colony-stimulating factor for osteochondral defect repair in a rat experimental model. Cartilage. 2014, 5:107-13. 10.1177\/1947603514520628","journal-title":"Cartilage"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290404","article-title":"Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients","volume":"29","author":"Hanly JG","year":"1986","unstructured":"Hanly JG, Hassan J, Whelan A, Feighery C, Bresnihan B. Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients. Arthritis Rheum. 1986, 29:480-7. 10.1002\/art.1780290404","journal-title":"Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/ar2547","article-title":"Plasma gelsolin as a biomarker of inflammation","volume":"10","author":"DiNubile MJ","year":"2008","unstructured":"DiNubile MJ. Plasma gelsolin as a biomarker of inflammation. Arthritis Res Ther. 2008, 10:124. 10.1186\/ar2547","journal-title":"Arthritis Res Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s43465-020-00089-4","article-title":"Gold-Induced Cytokine (GOLDIC(\u00ae)) injection therapy in patient with plantar fasciosis: a case report","volume":"54","author":"Melo SN","year":"2020","unstructured":"Melo SN, Ezekwesili A, Yurdi NA, Murrell WD, Maffulli N. Gold-Induced Cytokine (GOLDIC(\u00ae)) injection therapy in patient with plantar fasciosis: a case report. Indian J Orthop. 2020, 54:348-51. 10.1007\/s43465-020-00089-4","journal-title":"Indian J Orthop"},{"key":"ref42","article-title":"Anti-inflammatory gold-induced autologous cytokines treatment triggers heart failure after myocardial infarction","volume":"5","author":"Cordes F","year":"2017","unstructured":"Cordes F, Curaj A, Simsekyilmaz S, Schneider U, Liehn EA. Anti-inflammatory gold-induced autologous cytokines treatment triggers heart failure after myocardial infarction. Discoveries (Craiova). 2017, 5:e80.","journal-title":"Discoveries (Craiova)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202106_26055","article-title":"Intravenous gold-induced autologous serum injection therapy (Go ACT\u00ae) as a new treatment for seasonal pollen-based allergies","volume":"25","author":"Schneider U","year":"2021","unstructured":"Schneider U, Hollands P. Intravenous gold-induced autologous serum injection therapy (Go ACT\u00ae) as a new treatment for seasonal pollen-based allergies. Eur Rev Med Pharmacol Sci. 2021, 25:4121-7. 10.26355\/eurrev_202106_26055","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.29011\/2574-7754.100921","article-title":"Post Covid19 syndrome treatment using autologous gold-activated serum: a preliminary clinical study","volume":"7","author":"Schneider U","year":"2022","unstructured":"Schneider U, Hollands P, Schicht M, Paulsen F. Post Covid19 syndrome treatment using autologous gold-activated serum: a preliminary clinical study. Ann Case Rep. 2022, 7:10.29011\/2574-7754.100921","journal-title":"Ann Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315503-gold-induced-cytokine-goldic-for-the-management-of-knee-osteoarthritis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:47:45Z","timestamp":1730807265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315503-gold-induced-cytokine-goldic-for-the-management-of-knee-osteoarthritis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.73040","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}